IJOHNS  Vol.3 No.4 , July 2014
Differentiated Thyroid Cancer with Thyroglobulin Elevation and Negative Iodine Scintigraphy (TENIS Syndrome)
ABSTRACT

Background and Objectives: Following the initial management, some patients with differentiated thyroid cancer (DTC) develop a state of high thyroglobulin (Tg) and Negative Iodine Scintigraphy. The predisposing factors and outcome of this condition are unclear. In this study, our objectives were to analyze the characteristics of patients with high Tg level and negative Iodine scintigraphy and to determine the predictive factors for development of high Tg and negative scintigraphy. Patients and Methods: Retrospective study of 34 patients undergoing treatment for DTC, followed in the Nuclear Medicine department of the University HospitalSahloul Sousse between 1990 and 2006 and having a high Tg and negative Iodine scintigraphy. Fourteen patients had Tg between 2 and 10 ng/ml, 16 had Tg between 11 and 100 ng/ml and 4 patients had Tg more than 100 ng/ml. Results: There were 25 women and 9 men. The mean age was 51.65 years. In 94.1% of cases, the tumor was papillary carcinoma. Follicular tumors accounted for only 5.9%. The mean nodule size was3.26 cm. Capsular invasion was seen in 47.1% cases. The locoregional invasion was found in 35.3%. The lymph node extension was found in 84.8% of patients having lymph node surgery. Lymph node involvement was observed in 92.8% of patients with papillary cancer but it was found in 7.2% of patients with follicular cancers. Lymph node invasion was unilateral in 28.6% (N1a) and bilateral, contralateral or mediastinal in 71.4% (N1b). Initial level of Tg was as follows: 7 patients had Tg between 2 and 10 ng/ml, 14 patients had Tg between 11 and 100 ng/ml and 12 had Tg more than 100 ng/ml. The mean number of radioactive Iodine cure was 11.08 for patients with Tg more than 100 ng/ml with a significant difference (P = 0.001). Conclusion: Among epidemiological, pathological and clinical characteristics, lymph node invasion is the most frequent parameter found in patients with a DTC with high Tg level and negative Iodine scintigraphy.


Cite this paper
Sfar, R. , Kamoun, T. , Nouira, M. , Regaieg, H. , Ammar, N. , Charfi, H. , Bahloul, A. , Fredj, M. , Chatti, K. , Guezguez, M. and Essabbah, H. (2014) Differentiated Thyroid Cancer with Thyroglobulin Elevation and Negative Iodine Scintigraphy (TENIS Syndrome). International Journal of Otolaryngology and Head & Neck Surgery, 3, 149-153. doi: 10.4236/ijohns.2014.34028.
References
[1]   Chen Chan, A., Hin Lang, B.H. and Pun Wong, K. (2003) The Pros and Cons of Routine Central Compartment Neck Dissection for Clinically Nodal Negative (cN0) Papillary Thyroid Cancer. Gland Surgery, 2, 186-195.

[2]   Pagano, L., Klain, M., Pulcrano, M., et al. (2004) Follow-Up of Differentiated Thyroid Carcinoma. Minerva Endocrinologica, 29, 161-174.

[3]   Cooper, D., Doherty, G.M., Haugen, B.R., et al. (2009) Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 19, 1-44.
http://dx.doi.org/10.1089/thy.2009.0110

[4]   Luster, M., Clarke, S.E., Dietlein, M., et al. (2008) Guidelines for Radioiodine Therapy of Differentiated Thyroid Cancer. European Journal of Nuclear Medicine and Molecular Imaging, 35, 1941-1959.
http://dx.doi.org/10.1007/s00259-008-0883-1

[5]   Edward, B. (2011) The Problem of the Patient with Thyroglobulin Elevation but Negative Iodine Scintigraphy: The TENIS Syndrome. Seminars in Nuclear Medicine, 41, 113-120.
http://dx.doi.org/10.1053/j.semnuclmed.2010.10.002

[6]   Mazzaferri, E.L. (2005) Empirically Treating High Serum Thyroglobulin Levels. Journal of Nuclear Medicine, 46, 1079-1086.

[7]   Preissner, C.M., O’Kane, D.J., Singh, R.J., et al. (2003) Phantoms in the Assay Tube: Heterophile Antibody Interference in Serum Thyroglobulin Assays. The Journal of Clinical Endocrinology and Metabolism, 88, 3069-3074.
http://dx.doi.org/10.1210/jc.2003-030122

[8]   Mazzaferri, E.L., Robbins, R.J., Spencer, C.A., et al. (2003) A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma. The Journal of Clinical Endocrinology and Metabolism, 88, 1433-1441.
http://dx.doi.org/10.1210/jc.2002-021702

[9]   Clark, O.H. and Hoelting, T. (1994) Management of Patients with Differentiated Thyroid Cancer Who Have Positive Serum Thyroglobulin Levels and Negative Radioiodine Scans. Thyroidology, 4, 501-505.
http://dx.doi.org/10.1089/thy.1994.4.501

[10]   Dottorini, M.E., Vignati, A., Mazzuccheli, L., et al. (1997) Differentiated Thyroid Cancer in Children and Adolescents: A 37 Year Experience in 85 Patients. Journal of Nuclear Medicine, 38, 669-675.

[11]   Pacini, F., Agate, L., Elisei, R., et al. (2001) Outcome of Differentiated Thyroid Cancer with Detectable Serum Thyroglobulin and Negative Diagnostic Iodine Whole Body Scan: Comparison of Patients Treated with High I-131 Activities versus Untreated Patients. The Journal of Clinical Endocrinology and Metabolism, 86, 4092-4097.
http://dx.doi.org/10.1210/jcem.86.9.7831

[12]   Rosário, P.W., Maia, F.C., Barroso, A.L. and Purisch, S. (2005) Investigating Patients with Differentiated Thyroid Carcinoma and Elevated Serum Thyroglobulin but Negative Whole-Body Scan. Arquivos Brasileiros de Endocrinologia & Metabologia, 49, 246-252.

 
 
Top